Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-010668

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jayasuriya Anula · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X03/ownership.xml…